Literature DB >> 6713782

Lidocaine disposition--sex differences and effects of cimetidine.

L M Wing, J O Miners, D J Birkett, T Foenander, K Lillywhite, S Wanwimolruk.   

Abstract

The effects of pretreatment with cimetidine (1 gm daily for 3 days) on the disposition of lidocaine were examined in 18 healthy subjects, seven of whom were chronic cigarette smokers. Each subject received separate oral (200 mg) and intravenous (75 or 100 mg) doses of lidocaine before and after cimetidine. After cimetidine, lidocaine apparent oral clearance (Clo) reduced 42% +/- 7%; oral bioavailability increased 35% +/- 10%; and systemic clearance (Cls) and volume of distribution at steady-state (Vdss) decreased 21% +/- 6% and 20% +/- 7%. Elimination t 1/2 was unchanged. Calculated values for Cls after cimetidine based on reduction in Clo and consequent decrease in hepatic extraction ratio correlated significantly with observed values for Cls (r = 0.67). Women had larger Vdss (64% +/- 19%), longer t 1/2 (50% +/- 18%), and greater oral lidocaine bioavailability (63% +/- 29%) than did men. There was no sex difference in and no influence of cigarette smoking on the effects of cimetidine. The results indicate that cimetidine reduces metabolic clearance of lidocaine. The consequent reduced hepatic extraction explains the observed reduction in Cls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713782     DOI: 10.1038/clpt.1984.97

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.

Authors:  S R Smith; M J Kendall
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 4.  The influence of age and sex on the clearance of cytochrome P450 3A substrates.

Authors:  Monette M Cotreau; Lisa L von Moltke; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  The effect of ranitidine on the disposition of lignocaine.

Authors:  R A Robson; L M Wing; J O Miners; K J Lillywhite; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 6.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

7.  Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.

Authors:  J O Miners; L M Wing; K J Lillywhite; K J Smith
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

8.  Verapamil disposition--effects of sulphinpyrazone and cimetidine.

Authors:  L M Wing; J O Miners; K J Lillywhite
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

9.  Cimetidine alters pethidine disposition in man.

Authors:  D R Guay; R C Meatherall; J L Chalmers; G R Grahame
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 10.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.